“Methadone treatment is proving to be the most efficient way to wean people in Bangladesh from addiction to buprenorphine, a pharmaceutical drug, and health experts say it should be expanded to reach thousands more drug users to prevent the spread of HIV,” IRIN reports. The news service notes that “illegal use of pharmaceutical substances, mostly buprenorphine, is on the rise” in the country. “Buprenorphine was intended to be used to wean injecting drug users, also known as people who inject drugs (PWID), from narcotics like heroin, but has itself become a substance of addiction, with users injecting a liquid form of it,” the news service notes, adding, “Methadone, a pain reliever, suppresses withdrawal symptoms and blocks craving.”
Access to Health Services
In this post in Huffington Post’s “Healthy Living” blog, John-Manuel Andriote, a journalist and author living with HIV, writes, “For all of us living with HIV infection — Oct. 27 will mark seven years since my own diagnosis — the question we face daily, hopefully more consciously and deliberately than most, is how shall we live, knowing as we do that we will most assuredly die one day?” Reflecting on the XIX International AIDS Conference (AIDS 2012) that took place in Washington last month, he continues, “An AIDS-free generation is certainly a worthy goal,” but “even if tens of billions of additional dollars are allocated to address HIV/AIDS, even if the Republicans don’t succeed in inflicting their Darwinian ‘survival of the fittest’ upon the nation and the world, the question will continue to be what it has been for 31 years … Will we have the political will to end AIDS?”
“Ethiopia is preparing for a flood of medical doctors within ‘three to four years,’ an influx meant to save a public health system that has been losing doctors and specialists to internal and external migration,” IRIN reports. “‘We are now implementing strategies that intend to increase the current below-World Health Organization [WHO] standard number of medical doctors and retaining them in public hospitals,’ Tedros Adhanom, Ethiopia’s minister of health, told IRIN,” the news service writes. “‘We have now reached an enrollment rate of more than 3,100,’ [Adhanom] said,” adding, “The rate of enrollment in the country’s medical schools has increased tenfold from 2005, when it was below 300,” according to the news service.
In an opinion piece in the Guardian’s “Comment is Free” blog, Dean Baker, co-director of the Center for Economic and Policy Research, discusses potential policies contained within the “Trans-Pacific Partnership Agreement (TPP), a pact that the United States is negotiating with Australia, Canada, Japan and eight other countries in the Pacific region.” However, “[a]t this point, it’s not really possible to discuss the merits of the TPP since the governments are keeping the proposed text a secret from the public,” he says. Noting “[a] few items that have been leaked give us some insight as to the direction of this pact,” he discusses how the “pharmaceutical industry is … likely to be a big gainer” from the TPP if the pact includes “stronger and longer patent protection and also increased use of ‘data exclusivity.'”
Though many pregnant women are aware that treatment could save their lives and the lives of their infants if they test HIV-positive during prenatal care, a new study and literature review have found that a “[f]ear of being stigmatized as an AIDS patient is still a major barrier to good medical care for pregnant young women in many countries,” the New York Times reports. The study, published last week in PLoS Medicine, was “based on a survey of 1,777 women in rural Nyanza Province in Kenya,” according to the newspaper, which adds, “Only 44 percent of mothers in the province delivered in clinics, and the study found that a major obstacle was that they feared HIV tests.” The study’s author, Janet Turan, a professor of public health at the University of Alabama at Birmingham, in July also published “a review of multiple studies in many countries” that documented multiple accounts of “stigmatizing behavior,” the newspaper notes (McNeil, 8/27).
At the opening ceremony of World Water Week in Stockholm, Sweden, on Monday, the Food and Agriculture Organization (FAO) “launched a framework that will help combat food insecurity by providing methods to better manage water resources in agriculture and reduce waste,” the U.N. News Centre reports. “The initiative, entitled ‘Coping with water scarcity: An action framework for agriculture and food security’ [.pdf], seeks to encourage practices that will improve water management, such as modernizing irrigation schemes, recycling and re-using wastewater, implementing mechanisms to reduce water pollution, and storing rainwater at farms to reduce drought-related risks, among others,” the news service notes.
“Syrians are in urgent need of life-saving medicines following an escalation in fighting, which also threatens further food shortages, U.N. agencies warned on Tuesday,” Agence France-Presse reports (8/7). “Drugs for tuberculosis, hepatitis, hypertension, diabetes and cancer are urgently needed, as well as hemodialysis for kidney diseases, according to the WHO,” Reuters notes (8/7). “‘The recent escalation of clashes had resulted in substantial damages to the pharmaceutical plants located in rural Aleppo, Homs and Rural Damascus, where 90 percent of the country’s plants were located,’ a WHO spokesperson, Tarik Jasarevic, told reporters in Geneva today,” the U.N. News Centre writes. “Prior to the violence which has wracked the Middle Eastern country, Syria produced 90 percent of its medicines and drugs locally,” the news service notes (8/7).
Advocacy Groups Warn Trans-Pacific Partnership Could Affect Access To Low-Cost Medications, Bloomberg Reports
Bloomberg Businessweek examines how ongoing trade negotiations related to the Trans-Pacific Partnership could affect access to quality low-cost medications, including antiretrovirals, in low- and middle-income countries. “Protecting the patents of drug makers … as part of the Trans-Pacific Partnership has drawn criticism from groups such as Doctors Without Borders and Public Citizen,” and “[t]he proposed accord has also spurred calls from U.S. lawmakers for greater transparency about the negotiations,” the news service writes. “The multilateral talks, the main accord being pursued by President Barack Obama’s administration, … began with Australia, Brunei, Chile, Malaysia, New Zealand, Peru, Singapore, the U.S. and Vietnam [and] may expand after the parties invited Canada and Mexico,” the news service notes.
One Blog Examines GAVI Alliance's Efforts To Accelerate Introduction Of Hepatitis B Vaccines In Developing Countries
“I am looking forward to participating in the 2012 World Cancer Leaders’ Summit, to be held in Montreal, Canada on August 27,” GAVI Alliance Deputy CEO Helen Evans writes in this post in the One Blog. “This will be an opportunity to take stock of where the world is with regards to cancer prevention and treatment and to learn more about action to address the existing challenges to eliminating cancer as a life-threatening disease for future generations,” she writes, and discusses GAVI’s efforts to “accelerat[e] the introduction of hepatitis B vaccines in developing countries since 2000,” noting “GAVI has helped prevent an estimated 3.7 million deaths from liver cancer (caused by hepatitis B)” (8/21).
“India’s top court will hear final arguments … in a key patent dispute between Swiss drug maker Novartis and India’s patent office, a case that could curb India’s global position as a supplier of cut-price generic medicines,” Reuters reports. “Novartis appealed to the Supreme Court after its cancer medicine Glivec was refused a patent on the grounds the drug is not a new molecule but an amended version of a known compound,” the news service notes, adding, “Novartis has challenged this clause of Indian Patents Act.”